Massimo Offidani

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva et al. · Journal of Clinical Oncology · 2015 · 2.1K citations · Full text

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.

Livio Pagano, Morena Caira, Anna Candoni et al. · PubMed · 2006 · 908 citations

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo et al. · The Lancet Oncology · 2015 · 834 citations · Full text

Hematological Malignancy, Oncology, Dexamethasone Versus Bortezomib +8

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Michèle Cavo, Paola Tacchetti, Francesca Patriarca et al. · The Lancet · 2010 · 818 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Antonio Palumbo, Federica Cavallo, Francesca Gay et al. · New England Journal of Medicine · 2014 · 774 citations · Full text